Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4'-ethyl-2-methyl-3-piperidino)propiophenone
2. 4-empp
3. E-0646
1. 64840-90-0
2. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one
3. Eperisone [inn]
4. 4'-ethyl-2-methyl-3-piperidinopropiophenone
5. 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one
6. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone
7. Chebi:77070
8. Eperisone (inn)
9. 2m2p0551d3
10. (+-)-eperisone
11. Eperisonum
12. Eperisona
13. Eperisonum [inn-latin]
14. Eperisona [inn-spanish]
15. Ncgc00167973-01
16. Brn 1246496
17. Unii-2m2p0551d3
18. Eperisone [jan]
19. Eperisone [mi]
20. Eperisone [who-dd]
21. Schembl194769
22. Chembl1902981
23. Dtxsid5040671
24. 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-
25. Akos015960753
26. Db08992
27. Ac-12144
28. Db-054734
29. Hy-128891
30. Cs-0101898
31. Ft-0630750
32. D07898
33. 840e900
34. Q426401
35. Brd-a04252265-001-01-8
36. (2rs)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
| Molecular Weight | 259.4 g/mol |
|---|---|
| Molecular Formula | C17H25NO |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 259.193614421 g/mol |
| Monoisotopic Mass | 259.193614421 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 275 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03B - Muscle relaxants, centrally acting agents
M03BX - Other centrally acting agents
M03BX09 - Eperisone
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Eperisone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eperisone, including repackagers and relabelers. The FDA regulates Eperisone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eperisone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eperisone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eperisone supplier is an individual or a company that provides Eperisone active pharmaceutical ingredient (API) or Eperisone finished formulations upon request. The Eperisone suppliers may include Eperisone API manufacturers, exporters, distributors and traders.
click here to find a list of Eperisone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Eperisone DMF (Drug Master File) is a document detailing the whole manufacturing process of Eperisone active pharmaceutical ingredient (API) in detail. Different forms of Eperisone DMFs exist exist since differing nations have different regulations, such as Eperisone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Eperisone DMF submitted to regulatory agencies in the US is known as a USDMF. Eperisone USDMF includes data on Eperisone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eperisone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Eperisone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Eperisone Drug Master File in Japan (Eperisone JDMF) empowers Eperisone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Eperisone JDMF during the approval evaluation for pharmaceutical products. At the time of Eperisone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Eperisone suppliers with JDMF on PharmaCompass.
Eperisone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eperisone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eperisone GMP manufacturer or Eperisone GMP API supplier for your needs.
A Eperisone CoA (Certificate of Analysis) is a formal document that attests to Eperisone's compliance with Eperisone specifications and serves as a tool for batch-level quality control.
Eperisone CoA mostly includes findings from lab analyses of a specific batch. For each Eperisone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eperisone may be tested according to a variety of international standards, such as European Pharmacopoeia (Eperisone EP), Eperisone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eperisone USP).
LOOKING FOR A SUPPLIER?
